Analyst firms · BofA Securities · PFE

BofA Securities PFE price target and rating history

Pfizer Inc. (PFE) · Health Care

BofA Securities rates Pfizer Inc. (PFE) Neutral with a $29 price target, as of its latest action on Dec 10, 2024. It has published 3 rating actions on PFE since January 2022, including 1 upgrade and 1 downgrade. Across 8 firms with a PFE price target in the last 12 months, the median target is $26.50.

Current rating

Neutral

Price target

$29

Median target, all firms

$26.50

Actions on PFE

3

BofA Securities price target on PFE

Every BofA Securities rating on PFE

• Dec 10, 2024
  ResumeBofA Securities resumes coverage at Neutral, price target $29
• Jan 4, 2023
  DowngradeBofA Securities downgrades to Neutral from Buy, price target $60
• Jan 5, 2022
  UpgradeBofA Securities upgrades to Buy from Neutral, price target $59 to $70

How other firms rate PFE

Each firm's latest rating and stated target in the last 12 months.

Questions about BofA Securities and PFE

What is BofA Securities's price target for PFE?

BofA Securities's latest stated price target for Pfizer Inc. (PFE) is $29, from its action on Dec 10, 2024.

What is BofA Securities's rating on PFE?

BofA Securities rates PFE Neutral, a neutral rating, as of Dec 10, 2024.

When did BofA Securities last change its view on PFE?

On Dec 10, 2024, BofA Securities resumes coverage at Neutral, price target $29.

How does BofA Securities's PFE target compare with other analysts?

Across 8 firms with a PFE price target in the last 12 months, the median target is $26.50.

More PFE rating histories

• Daiwa4
• UBS4
• Wells Fargo3
• Leerink Partners5
• Morgan Stanley5

All BofA Securities ratingsPFE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.